IN-DATE
USH83AT: Bard Usher Peripheral Support Catheter: Angled Tapered 83cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $11.50 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 2 box of 1 |
| Status: | expired |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Additional Details
Bard Usher Support Catheter
- Stainless steel, braided shaft construction for greater catheter push and torquability
- Hemostatic valve offering complete hemostasis to minimize blood loss
- Enhanced angle retention to steer the Crosser® Catheter tip towards flush occlusions or lesions on an angle
AccessGUDID Info
- FDA Product Code: DQY
- FDA Product Code Name: CATHETER, PERCUTANEOUS
- GMDN Term Code: 17846
- GMDN Term Name: Vascular guide-catheter, single-use
- GMDN Term Description: A flexible tube intended to be used for the percutaneous transluminal passage and placement of a diagnostic/interventional catheter, lead (e.g., pacing lead, balloon dilatation catheter), needle or guidewire through its lumen(s), within the vascular system. It may be rigid or flexible, non-steerable or steerable, single or multiple lumen(s), and the distal section can have a variety of preformed shapes (e.g., straight, hockey stick). It is not intended solely for infusion, is not intended to access superselective small vessels, and does not include a transseptal needle. It may include a disposable percutaneous introduction set or shaft visualization electrodes. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
